Novel mycobacterial sulfation pathway proteins and polypeptides related thereto, as well as nucleic acid compositions encoding the same, are provided. The subject polypeptide and nucleic acid compositions find use in a variety of applications, including research, diagnostic, and therapeutic agent screening applications. Also provided are methods of inhibiting growth and/or virulence of a pathogenic mycobacterium, and methods of treating disease conditions associated with a pathogenic mycobacterium, particularly by administering an inhibitor of a mycobacterial sulfation pathway protein. The present invention further provides genetically modified mycobacteria having a defect in a sulfation pathway enzyme gene; and immunogenic compositions that include such genetically modified mycobacteria.

 
Web www.patentalert.com

< Diamines as modulators of chemokine receptor activity

< Methods of inducing an HIV specific response using a Vpr-specific epitope

> Erythrocyte sedimentation rate (ESR) test measurement instrument of unitary design and method of using the same

> Treatment of viral infections using prodrugs of 2,3-dideoxy,3-fluoroguanosine

~ 00226